Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial
Clinical Infectious Diseases · 11.09.2023 · 77 (5) · 687-695
DOI: 10.1093/cid/ciad257 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.05.2023. Verfasst von Tanja A Kuut und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Psychology, Amsterdam UMC location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Netherlands Organization for Health Research and Development, National Health and Medical Research Council.
Abstract (Originalsprache)
Background
Severe fatigue following coronavirus disease 2019 (COVID-19) is prevalent and debilitating. This study investigated the efficacy of cognitive-behavioral therapy (CBT) for severe fatigue following COVID-19.
Methods
A multicenter, 2-arm randomized controlled trial was conducted in the Netherlands with patients being severely fatigued 3–12 months following COVID-19. Patients (N = 114) were randomly assigned (1:1) to CBT or care as usual (CAU). CBT, targeting perpetuating factors of fatigue, was provided for 17 weeks. The primary outcome was the overall mean difference between CBT and CAU on the fatigue severity subscale of the Checklist Individual Strength, directly post-CBT or CAU (T1), and after 6 months (T2). Secondary outcomes were differences in proportions of patients meeting criteria for severe and/or chronic fatigue, differences in physical and social functioning, somatic symptoms, and problems concentrating between CBT and CAU.
Results
Patients were mainly nonhospitalized and self-referred. Patients who received CBT were significantly less severely fatigued across follow-up assessments than patients receiving CAU (−8.8 [95% confidence interval {CI}, −11.9 to −5.8]); P < .001), representing a medium Cohen's d effect size (0.69). The between-group difference in fatigue severity was present at T1 (−9.3 [95% CI, −13.3 to −5.3]) and T2 (−8.4 [95% CI, −13.1 to −3.7]). All secondary outcomes favored CBT. Eight adverse events were recorded during CBT, and 20 during CAU. No serious adverse events were recorded.
Conclusions
Among patients, who were mainly nonhospitalized and self-referred, CBT was effective in reducing fatigue. The positive effect was sustained at 6-month follow-up. Clinical Trials Registration Netherlands Trial Register NL8947.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Psychology, Amsterdam UMC location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam Public Health, Amsterdam UMC location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Department of Lung Medicine, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
- Center for Experimental and Molecular Medicine, Amsterdam UMC location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Department of Medical Psychology, Jeroen Bosch Hospital, 5223 GZ Den Bosch, The Netherlands.
- Amsterdam Institute for Infection and immunity, Amsterdam UMC location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
ORCID-Profile: Tanja A Kuut
Förderung
- Netherlands Organization for Health Research and Development
- National Health and Medical Research Council
Zitieren
APA
Kuut, T. A., Müller, F., Csorba, I., Braamse, A., Aldenkamp, A., Appelman, B., Assmann-Schuilwerve, E., Geerlings, S. E., Gibney, K. B., Kanaan, R. A. A., Mooij-Kalverda, K., Olde Hartman, T. C., Pauëlsen, D., Prins, M., Slieker, K., van Vugt, M., Keijmel, S. P., Nieuwkerk, P., Rovers, C. P., & Knoop, H. (2023). Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clinical Infectious Diseases, 77(5), 687-695. https://doi.org/10.1093/cid/ciad257
Vancouver
Kuut TA, Müller F, Csorba I, Braamse A, Aldenkamp A, Appelman B, et al. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clinical Infectious Diseases. 2023;77(5):687-695. doi:10.1093/cid/ciad257
BibTeX
@article{Kuut2023,
author = {Kuut, Tanja A and Müller, Fabiola and Csorba, Irene and Braamse, Annemarie and Aldenkamp, Arnoud and Appelman, Brent and Assmann-Schuilwerve, Eleonoor and Geerlings, Suzanne E and Gibney, Katherine B and Kanaan, Richard A A and Mooij-Kalverda, Kirsten and Olde Hartman, Tim C and Pauëlsen, Dominique and Prins, Maria and Slieker, Kitty and van Vugt, Michele and Keijmel, Stephan P and Nieuwkerk, Pythia and Rovers, Chantal P and Knoop, Hans},
title = {Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {5},
pages = {687--695},
doi = {10.1093/cid/ciad257}
}
EUVIMED